Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Summary
To evaluate the efficacy and safety of tenofovir disoproxil fumarate in the treatment of Parkinson's disease. The changes of motor symptoms and the occurrence of adverse reactions in early Parkinson's disease patients who took tenofovir disoproxil fumarate and did not take Tenofovir disoproxil fumarate at different time points were compared.
Official title: Efficacy and Safety of Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-01-23
Completion Date
2025-12-31
Last Updated
2025-02-17
Healthy Volunteers
No
Conditions
Interventions
Tenofovir Disoproxil Fumarate
take tenofovir disoproxil fumarate 300mg/d
Locations (1)
Guohua Zhao
Hangzhou, Zhejiang, China